Search all trials

Find therapies in clinical trials near you – page 69

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Hodgkin's disease

Not recruiting

Registered drugNo placebo

Study Comparing Pembrolizumab and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Brentuximab Vedotin

Contact Research Centre

T-cell lymphoma

Not recruiting

InvestigationalNo placebo

Study of Tolinapant with Decitabine and Cedazuridine for Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cedazuridine

Contact Research Centre

Cutaneous T-cell lymphoma+1

Not recruiting

InvestigationalNo placebo

Study of Linperlisib for Patients with Relapsed or Refractory Peripheral T/NK Cell or Cutaneous T Cell Lymphoma

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Linperlisib

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carfilzomib

Contact Research Centre

Hormone-refractory prostate cancer

Not recruiting

Registered drugNo placebo

Study Comparing [177Lu]LU-PSMA-I&T and Hormone Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Hormone-refractory prostate cancer+1

Not recruiting

Registered drug

Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Enzalutamide

Contact Research Centre

Autoimmune haemolytic anaemia+1

Not recruiting

Registered drugNo placebo

Study for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Burkitt's lymphoma+1

Not recruiting

Registered drugNo placebo

Study on Brexucabtagene Autoleucel for Adults with Relapsed or Refractory Burkitt Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Alpelisib

Contact Research Centre

Hairy cell leukaemia

Not recruiting

Registered drugNo placebo

Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Hairy Cell Leukemia

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Mesna

Contact Research Centre

Richter's syndrome

Not recruiting

Registered drugNo placebo

Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Richter Transformation (RT)

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Alpelisib

Contact Research Centre

Waldenstrom's macroglobulinaemia+1

Not recruiting

Registered drugNo placebo

Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Waldenstrom Macroglobulinemia Using a Drug Combination

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Systemic mastocytosis

Not recruiting

Investigational

Study on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:3,4-Dimethyl-N-(2-Phenyl-1H-Pyrrolo[2,3-B]Pyridin-5-Yl)-1H-Pyrazole-5-Carboxamide

Contact Research Centre

Find therapies in clinical trials near you – page 69

885 trials match your criteria

Hodgkin's disease

Study Comparing Pembrolizumab and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma

T-cell lymphoma

Study of Tolinapant with Decitabine and Cedazuridine for Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

Cutaneous T-cell lymphoma+1

Study of Linperlisib for Patients with Relapsed or Refractory Peripheral T/NK Cell or Cutaneous T Cell Lymphoma

Plasma cell myeloma

Study to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Hormone-refractory prostate cancer

Study Comparing [177Lu]LU-PSMA-I&T and Hormone Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer

Hormone-refractory prostate cancer+1

Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Autoimmune haemolytic anaemia+1

Study for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab

Burkitt's lymphoma+1

Study on Brexucabtagene Autoleucel for Adults with Relapsed or Refractory Burkitt Lymphoma

Hairy cell leukaemia

Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Hairy Cell Leukemia

Richter's syndrome

Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Richter Transformation (RT)

Waldenstrom's macroglobulinaemia+1

Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Waldenstrom Macroglobulinemia Using a Drug Combination

Systemic mastocytosis

Study on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.